Boston Scientific said its first-quarter net income roughly doubled as demand continued to grow worldwide for its stents, ...

Boston Scientific (NYSE:BSX) today reported first-quarter financial results that came in ahead of the Wall Street forecast.

CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including ...

On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech ...

April 22 () - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a ...

Boston Scientific stock rallied Wednesday despite cutting its 2026 outlook. An analyst says this could offer a reset for shares.

Boston Scientific (NYSE:BSX | BSX Price Prediction) stock has taken a beating in 2026 after management cut full-year guidance ...